Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.

Badio, Moses; Lhomme, Edouard; Kieh, Mark; Beavogui, Abdoul Habib; Kennedy, Stephen B; Doumbia, Seydou; Leigh, Bailah; Sow, Samba O; Diallo, Alpha; Fusco, Daniela; +16 more... Kirchoff, Matthew; Termote, Monique; Vatrinet, Renaud; Wentworth, Deborah; Esperou, Helène; Lane, H Clifford; Pierson, Jerome; Watson-Jones, Deborah; Roy, Céline; D'Ortenzio, Eric; Greenwood, Brian; Chêne, Genevieve; Richer, Laura; Neaton, James D; Yazdanpanah, Yazdan; PREVAC study team; PREVAC study team; (2021) Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries. Trials, 22 (1). 583-. ISSN 1745-6215 DOI: https://doi.org/10.1186/s13063-021-05572-3

Abstract

Following the publication of the original article [1], we were notified of an error in the affiliation of 3 authors of the article: Celine Roy, Laura Richert and Genevieve Chene. Their affiliation was initially mentioned as: “Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia” However, their correct affiliation is: Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.tp.

Additional Information

Item Type	Article
Faculty and Department	Faculty of Infectious and Tropical Diseases > Dept of Clinical Research Faculty of Infectious and Tropical Diseases > Dept of Disease Control
Research Centre	Vaccine Centre
PubMed ID	34470655
Elements ID	165979